Pennsylvania Business Report
Obesity drug developer Alveus Therapeutics closes $197M Series A financing
Philadelphia-based Alveus Therapeutics, a clinical-stage biotechnology company developing obesity and metabolic disease therapies, recently raised $197 million in Series A financing. This was the second and final closing in this financing round. “The backing of specialist healthcare investors with deep domain expertise reflects strong momentum for Alveus, driven by our differentiated portfolio, the strength of our team, and the scale of the opportunity in obesity and metabolic disease,”...
Read More
Eddystone Generating Station ordered to stay online through May
February 25, 2026
State PUC votes to investigate natural gas rate increase request
February 24, 2026
Conshohoken-based Cencora to merge animal health unit with Covetrus
February 23, 2026
Siemens Energy becomes a 6K Additive supplier
February 26, 2026
Robotics Innovation Center at Carnegie Mellon signs first tenant
February 25, 2026
Cargas purchases customer engagement platform
February 25, 2026
Erie Insurance Group president and CEO retiring
February 24, 2026
Doceo launches business services division
February 24, 2026
Harbor Compliance receives undisclosed investment
February 23, 2026
Everest Infrastructure Partners receives $500M investment
February 23, 2026
Florida architectural firm purchases Klavon Design Associates
February 20, 2026
Kraft Heinz Company appoints Nicolas Amaya as new president
February 20, 2026
Indiana company purchases FORTA
February 19, 2026
Dura-Bond inks multi-year contract with TC Energy for steel pipe
February 19, 2026